WritingGuidelinesforCMCDossiersforInitialInvestigationalNewDrugApplicationofTherapeuticRecombinantProteinDrugs-Pharmaceutical & Cosmetic

中文|ENGLISH

Top news

NMPA approved Zongertinib for ...[2025-09-03]
Agenda of 15th CIMDR-Medical D...[2025-08-12]
Li Li meets with head of Uzbek...[2025-07-04]
The 4th Seminar on the Researc...[2025-06-18]
Policy measures to advance dru...[2025-06-16]
NMPA holds meeting to review Q...[2025-06-16]
Notice - Registration Form for...[2018-01-02]

Regulatory News

Pharmaceutical & Cosmetic

TCM

Medical Devices

search


topic
content
到

Pharmaceutical & Cosmetic

Position ： Home Page >> Regulatory News >> Pharmaceutical & Cosmetic

Writing Guidelines for CMC Dossiers for Initial Investigational New Drug Application of Therapeutic Recombinant Protein Drugs

　　　　Pubtime： 2026-06-09

Links

Address: China & middot; Beijing's xizhimen north street, maple blue international centre, 32 B: room 1106, building 11 layer phone 010-82212866 fax: 010-82212857

EICP for E_mail:ccfdie@ccfdie.org website: www.ccfdie.org for the record number: Beijing no. 06008179

China's food and drug international copyright exchange center all zip code ：100082